US Supreme Court declines ex-InterMune CEO appeal
This article was originally published in Scrip
Executive Summary
The US Supreme Court on 16 December declined to hear an appeal from Dr Scott Harkonen, the former CEO of InterMune, who was convicted in September 2009 of wire fraud for his role in creating and disseminating an August 2002 press release deemed by federal prosecutors as containing "fraudulent" statements about Actimmune (Interferon gamma-1b), the company's bioengineered form of interferon gamma, a protein that acts as a biologic response modifier through stimulation of the human immune system.